{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:13:02Z","timestamp":1785402782563,"version":"3.56.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    Artificial intelligence (AI) is increasingly used in drug repurposing to integrate chemical, biological, and clinical data and to prioritize candidate drug\u2013disease associations. Yet current evaluation practices remain dominated by benchmark metrics such as AUROC, AUPRC, F1, or top-\n                    <jats:inline-formula>\n                      <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"m1\">\n                        <mml:mrow>\n                          <mml:mi>k<\/mml:mi>\n                        <\/mml:mrow>\n                      <\/mml:math>\n                    <\/jats:inline-formula>\n                    retrieval, which do not by themselves establish pharmacological credibility. A useful prediction is not merely one that scores highly on retrospective datasets, but one that can be connected to a biologically plausible mechanism, safety-relevant context, and a traceable evidentiary basis for experimental follow-up. Mechanistic explainability should therefore be treated as a core objective for translationally oriented AI-enabled repurposing, while also emphasizing that explainability complements rather than replaces experimental validation. Specifically, explanations should connect drugs, targets, pathways, phenotypes, and clinical outcomes in ways that are intelligible to pharmacologists and compatible with experimental prioritization, translational decision-making, and emerging regulatory expectations. We identify a central gap in the literature: many explainability methods emphasize feature attribution or local model transparency, but rarely produce pharmacology-aligned evidence chains that also communicate uncertainty, robustness, and provenance. We introduce biomedical knowledge graphs and neurosymbolic approaches as a promising foundation for more credible repurposing systems because they can support relational inference, structured mechanistic reasoning, and provenance-aware explanation. We further argue that future evaluation should extend beyond predictive accuracy to include mechanistic coherence, uncertainty, robustness, and provenance (MURP) for experimental pharmacology, ideally within workflows that integrate computational prediction with laboratory and, where feasible, real-world validation. Reframing success in this way would improve rigor, translational relevance, and regulatory readiness in AI-driven drug repurposing.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2026.1860953","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T08:31:02Z","timestamp":1785400262000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["From benchmark accuracy to pharmacological credibility: why mechanistic explainability must define the next generation of AI for drug repurposing"],"prefix":"10.3389","volume":"17","author":[{"given":"Markus","family":"Bertl","sequence":"first","affiliation":[{"name":"Advanced Research and Innovation Group, Unisys","place":["Blue Bell, PA, United States"]},{"name":"Department of Information Systems and Operations Management, Vienna University of Economics and Business","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Sinno","sequence":"additional","affiliation":[{"name":"Advanced Research and Innovation Group, Unisys","place":["Blue Bell, PA, United States"]},{"name":"School of Computing, Newcastle University","place":["Newcastle upon Tyne, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41597-023-01974-x","article-title":"Evaluating explainability for graph neural networks","volume":"10","author":"Agarwal","year":"2023","journal-title":"Sci. Data"},{"key":"B2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrg2918","article-title":"Network medicine: a network-based approach to human disease","volume":"12","author":"Barab\u00e1si","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"12809","DOI":"10.1007\/s00521-024-09960-z","article-title":"Neuro-symbolic artificial intelligence: a survey","volume":"36","author":"Bhuyan","year":"2024","journal-title":"Neural Comput. Appl."},{"key":"B4","unstructured":"Benchmarking the impact of data leakage on the performance of knowledge graph embedding models for biomedical link prediction\n          \n          \n            \n              Bri\u00e8re\n              G.\n            \n            \n              Stosskopf\n              T.\n            \n            \n              Loire\n              B.\n            \n            \n              Baudot\n              A.\n            \n          \n          10.1101\/2025.01.23.634511"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e00836","DOI":"10.1016\/j.neurot.2026.e00836","article-title":"Network-based prediction and real-world patient data observation identify doxycycline as a repurposable drug in Alzheimer\u2019s disease","volume":"23","author":"Bykova","year":"2026","journal-title":"Neurotherapeutics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s11633-024-1510-8","article-title":"A comprehensive survey on trustworthy graph neural networks: privacy, robustness, fairness, and explainability","volume":"21","author":"Dai","year":"2024","journal-title":"Mach. Intell. Res."},{"key":"B7","article-title":"Go for a walk and arrive at the answer: reasoning over paths in knowledge bases using reinforcement learning","volume-title":"International Conference on Learning Representations (ICLR)","author":"Das","year":"2018"},{"key":"B8","volume-title":"Mars: A Neurosymbolic Approach for Interpretable Drug Discovery","author":"DeLong","year":""},{"key":"B9","doi-asserted-by":"publisher","first-page":"7822","DOI":"10.1109\/TNNLS.2024.3420218","article-title":"Neurosymbolic AI for reasoning over knowledge graphs: a survey","volume":"36","author":"DeLong","year":"2025","journal-title":"IEEE Trans. Neural Netw. Learn. Syst."},{"key":"B10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/978-3-031-00129-1_51","article-title":"Neuro-symbolic xai: application to drug repurposing for rare diseases","volume-title":"International Conference on Database Systems for Advanced Applications","author":"Dranc\u00e9","year":"2022"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/s43587-021-00138-z","article-title":"Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for alzheimer\u2019s disease","volume":"1","author":"Fang","year":"2021","journal-title":"Nat. Aging"},{"key":"B12","first-page":"1050","article-title":"Dropout as a bayesian approximation: representing model uncertainty in deep learning","volume-title":"International Conference on Machine Learning","author":"Gal","year":"2016"},{"key":"B13","doi-asserted-by":"publisher","first-page":"12387","DOI":"10.1007\/s10462-023-10448-w","article-title":"Neurosymbolic AI: the 3rd wave","volume":"56","author":"Garcez","year":"2023","journal-title":"Artif. Intell. Rev."},{"key":"B14","first-page":"1321","article-title":"On calibration of modern neural networks","volume-title":"International Conference on Machine Learning","author":"Guo","year":"2017"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e26726","DOI":"10.7554\/eLife.26726","article-title":"Systematic integration of biomedical knowledge prioritizes drugs for repurposing","volume":"6","author":"Himmelstein","year":"2017","journal-title":"elife"},{"key":"B16","volume-title":"A Study on neuro-symbolic Artificial Intelligence: Healthcare Perspectives","author":"Hossain","year":"2025"},{"key":"B17","doi-asserted-by":"publisher","first-page":"16587","DOI":"10.1038\/s41598-024-67163-x","article-title":"Explainable drug repurposing via path based knowledge graph completion","volume":"14","author":"Jim\u00e9nez","year":"2024","journal-title":"Sci. Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3390\/biology11081208","article-title":"Data incompleteness may form a hard-to-overcome barrier to decoding life\u2019s mechanism","volume":"11","author":"Kondratyeva","year":"2022","journal-title":"Biology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41597-022-01510-3","article-title":"The heterogeneous pharmacological medical biochemical network pharmebinet","volume":"9","author":"K\u00f6nigs","year":"2022","journal-title":"Sci. Data"},{"key":"B20","doi-asserted-by":"publisher","first-page":"6402","DOI":"10.5555\/3295222.3295387","article-title":"Simple and scalable predictive uncertainty estimation using deep ensembles","volume":"30","author":"Lakshminarayanan","year":"2017","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e70049","DOI":"10.1002\/wcms.70049","article-title":"Explainable artificial intelligence in drug discovery: bridging predictive power and mechanistic insight","volume":"15","author":"Lavecchia","year":"2025","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"key":"B22","first-page":"375","article-title":"Neural multi-hop reasoning with logical rules on biomedical knowledge graphs","volume-title":"The Semantic Web \u2013 18th International Conference, ESWC 2021","author":"Liu","year":"2021"},{"key":"B23","first-page":"4765","article-title":"A unified approach to interpreting model predictions","volume":"30","author":"Lundberg","year":"2017","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"B24","doi-asserted-by":"publisher","first-page":"19620","DOI":"10.5555\/3495724.3497370","article-title":"Parameterized explainer for graph neural network","volume":"33","author":"Luo","year":"2020","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"B25","first-page":"3137","article-title":"Anytime bottom-up rule learning for knowledge graph completion","volume-title":"Proceedings of the Twenty-Eighth International Joint Conference on Artificial Intelligence (IJCAI 2019)","author":"Meilicke","year":"2019"},{"key":"B26","doi-asserted-by":"publisher","first-page":"btad080","DOI":"10.1093\/bioinformatics\/btad080","article-title":"The scalable precision medicine open knowledge engine (spoke): a massive knowledge graph of biomedical information","volume":"39","author":"Morris","year":"2023","journal-title":"Bioinformatics"},{"key":"B27","first-page":"4624","article-title":"Rewarding explainability in drug repurposing with knowledge graphs","volume-title":"Proceedings of the Thirty-Fourth International Joint Conference on Artificial Intelligence (IJCAI 2025)","author":"Nunes","year":"2025"},{"key":"B28","article-title":"Safran: an interpretable, rule-based link prediction method outperforming embedding models","volume-title":"Proceedings of the 3rd Conference on Automated Knowledge Base Construction (AKBC 2021)","author":"Ott","year":"2021"},{"key":"B29","doi-asserted-by":"publisher","first-page":"bbae461","DOI":"10.1093\/bib\/bbae461","article-title":"Knowledge graphs for drug repurposing: a review of databases and methods","volume":"25","author":"Perdomo-Quinteiro","year":"2024","journal-title":"Brief. Bioinform."},{"key":"B30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B31","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1145\/2939672.2939778","article-title":"\u201c Why should I trust you?\u201d explaining the predictions of any classifier","volume-title":"Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining","author":"Ribeiro","year":"2016"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e44359","DOI":"10.7759\/cureus.44359","article-title":"Artificial intelligence and machine learning in pharmacological research: bridging the gap between data and drug discovery","volume":"15","author":"Singh","year":"2023","journal-title":"Cureus"},{"key":"B33","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.cell.2020.01.021","article-title":"A deep learning approach to antibiotic discovery","volume":"180","author":"Stokes","year":"2020","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41573-025-01164-x","article-title":"Computational drug repurposing: approaches, evaluation of in silico resources and case studies","volume":"24","author":"Tanoli","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"B35","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41586-023-06887-8","article-title":"Discovery of a structural class of antibiotics with explainable deep learning","volume":"626","author":"Wong","year":"2024","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","first-page":"9240","DOI":"10.5555\/3454287.3455116","article-title":"GNNExplainer: generating explanations for graph neural networks","volume":"32","author":"Ying","year":"2019","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"B37","first-page":"12241","article-title":"On explainability of graph neural networks via subgraph explorations","author":"Yuan","year":"2021"},{"key":"B38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41591-024-03434-4","article-title":"Artificial intelligence in drug development","volume":"31","author":"Zhang","year":"2025","journal-title":"Nat. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-ncov\/sars-cov-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell Discovery"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1860953\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T08:31:06Z","timestamp":1785400266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1860953\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":39,"alternative-id":["10.3389\/fphar.2026.1860953"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1860953","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"article-number":"1860953"}}